Joanna graduated from the University of Durham with a First Class MChem Honours degree in Chemistry.
In 2006 Joanna joined a major global pharmaceutical company and worked in their late-stage research and development department firstly as an analytical chemist and then as a solid state scientist. Joanna worked on a number of late stage pharmaceutical projects with multi-discipline project teams. Joanna helped define the solid state strategies, such as the selection of a suitable physical form and the control of the physical form, for a number of projects. Joanna also authored the solid state sections of regulatory submissions.
In September 2014 Joanna joined the in-house IP department of the pharmaceutical company. During her time in this department, Joanna gained experience in patent drafting and prosecution. Joanna was responsible for managing the IP portfolio of a number of early and late-stage pharmaceutical projects.
Joanna joined HGF’s Manchester office in October 2017 and has worked with a number of different clients including pharmaceutical companies and Universities. Joanna has been involved with preparing submissions for opposition and appeal proceedings before the EPO.
MChem in Chemistry
A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted. To many …Read article
Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …Read article
HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …Event details
The advent of commercial launch capabilities has opened up space as a unique frontier for innovation. However, in space, any acts of patent infringement almost always go unseen. Thus, it’s …Read article
Any communications sent from the EPO on or after 1 November 2023 will no longer have the “ten day rule” applied to them. This means that communications are deemed to …Read article
HGF is pleased to invite you to our upcoming German-language seminar on “In- and Out-licensing of Technologies” in Salzburg and Dresden. The seminar will offer you the opportunity to gain …Event details
Bioforward, OBN’s ‘Roadmap for Growth’ Life Sciences event is set to take place at The King’s Centre in Oxford on Tuesday 26th September 2023. This event is designed to provide the support, skills, know-how …Event details
The integration of artificial intelligence (AI) into healthcare has ushered in a new era of personalised medicine, promising more effective and tailored treatments for patients. Traditional medical approaches often adopt …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.